Beam Therapeutics up 10.83% since entry, model coverage complete

Beam Therapeutics is in week 11 of a buy signal, up 10.83% since entry. All 3 targets of our most advanced model have already been hit: coverage is complete, and the remaining share of the position continues with a trailing stop on the Inversion Point. The setup quality indicator sits at 68 out of 100, in a maturity squeeze, with a medium signal strength of 66 out of 100.